rs188146580
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001101362.3(KBTBD13):āc.333C>Gā(p.Asp111Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000189 in 1,513,854 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001101362.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KBTBD13 | NM_001101362.3 | c.333C>G | p.Asp111Glu | missense_variant | 1/1 | ENST00000432196.5 | NP_001094832.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KBTBD13 | ENST00000432196.5 | c.333C>G | p.Asp111Glu | missense_variant | 1/1 | 6 | NM_001101362.3 | ENSP00000388723.2 |
Frequencies
GnomAD3 genomes AF: 0.000941 AC: 143AN: 151956Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000221 AC: 25AN: 113304Hom.: 0 AF XY: 0.000223 AC XY: 14AN XY: 62808
GnomAD4 exome AF: 0.000103 AC: 140AN: 1361788Hom.: 1 Cov.: 56 AF XY: 0.0000893 AC XY: 60AN XY: 671818
GnomAD4 genome AF: 0.000960 AC: 146AN: 152066Hom.: 0 Cov.: 34 AF XY: 0.000874 AC XY: 65AN XY: 74378
ClinVar
Submissions by phenotype
Nemaline myopathy 6 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | KBTBD13: BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 18, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at